MLICM
TELA icon

Metropolitan Life Insurance Company (MetLife)’s TELA Bio TELA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-877
Closed -$7.02K – 2387
2023
Q3 		$7.02K Hold
877
– – ﹤0.01% 2356
2023
Q2 		$8.88K Buy
+877
New +$8.97K ﹤0.01% 2356

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TELA Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of TELA Bio (TELA) in Q4 2023, closing a stake of 877 shares — an estimated $7.02K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TELA in Q2 2023 and held it in 2 quarters. The position peaked at $8.88K in Q2 2023. 60 funds tracked by Wall St. Rank hold TELA as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining TELA Bio position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 877 TELA Bio shares in Q4 2023, an estimated $7.02K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in TELA Bio in Q2 2023 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s TELA Bio position peaked at $8.88K in Q2 2023.
  • 60 funds tracked by Wall St. Rank held TELA Bio as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.